InscoBio launches 'Biomedica' based on patented substance TGF-β1... "Strengthening brand portfolio"
[Asia Economy Reporter Hyunseok Yoo] InscoBi announced on the 26th that it will launch a new dermocosmetic brand, ‘Biomedica,’ containing the patented substance TGF-β1 (Transforming Growth Factor Beta 1), which has high efficacy in skin regeneration.
Biomedica is a high-performance premium anti-aging brand with Transforming Growth Factor Beta 1 protein TGF-β1, which is 100% identical to skin DNA, as its main ingredient. TGF-β1, successfully mass-produced through long-term research by InscoBi’s bio-subsidiary Cellumed, acts extensively from the epidermis to the dermis of the skin. It directly synthesizes collagen, elastin, and hyaluronic acid, showing excellent effects in improving skin aging.
Because it promotes skin tissue regeneration and recovery, it is a noteworthy ingredient widely used in wound healing pharmaceuticals such as for skin burns and scars.
InscoBi has continuously developed bio-cosmeceuticals by utilizing the technological capabilities of its bio-subsidiary Cellumed. ‘Themicoce,’ containing Cellumed’s protein FGF7, consistently achieves high sales on home shopping channels. Additionally, ‘Biplasti,’ based on bee venom from the bio-subsidiary Apimez, has recorded sold-out runs on Lotte Home Shopping, establishing itself as a premium anti-aging brand.
A company representative stated, “Biomedica, the culmination of InscoBi’s dermocosmetic research, actively reflected beauty trends and consumer needs by collaborating with beauty specialist show host Han Chang-seo from the product development stage,” adding, “Based on this, it is expected to become a high-end anti-aging serum that can solve concerns about wrinkle improvement and skin aging prevention all at once.”
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Bull Market End Signal? Securities Firm Warns: "Sell SK hynix 'At This Moment'"
- "Greater Impact on Women Than Men"... The 'Diet Trap' That Causes Sleepless Nights and Suffering
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
They continued, “Through collaboration with bio-subsidiaries and leveraging experience in launching dermocosmetic brands, Biomedica is expected to successfully settle in the dermocosmetic market,” and added, “By launching Biomedica following Themicoce and Biplasti to strengthen the brand portfolio, the dermocosmetic business is anticipated to expand further.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
